Treatment of depression

Details Treatment of depression Treatment of depression

A - Human Necessities

61

K

A61K 31/05 (2006.01) A61K 31/055 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61K 31/167 (2006.01) A61K 31/194 (2006.01) A61K 31/29 (2006.01) A61K 31/343 (2006.01) A61K 31/415 (2006.01) A61K 31/485 (2006.01) A61K 31/5415 (2006.01) A61K 31/616 (2006.01) A61K 45/06 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2689350

There is described a compound selected from the group consisting of tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof, for the treatment or alleviation of depression.

L'invention décrit un composé choisi dans le groupe constitué par le tramadol, le resveratrol, l'acétaminophène, le xorphanol, le cinfénoac, le furcloprofène, le subsalicylate de bismuth, l'énofélast, le triflusal, le kétorfanol, l'indriline, le furofénac, la cizolirtine, la dacémazine, la démelvérine et la fénéthazine, et des dérivés et/ou combinaisons de ceux-ci, pour le traitement ou le soulagement de la dépression.

Affiliated with

Also associated with

Rating

Treatment of depression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of depression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1725446